openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Aytu BioScience, Inc. (NASDAQ: AYTU)

11-17-2021 03:20 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Aytu BioScience, Inc. (NASDAQ: AYTU) shares over potential wrongdoing.

An investigation on behalf of investors in Aytu BioScience, Inc. (NASDAQ: AYTU) shares over potential wrongdoing.

An investigation was announced for long-term investors in shares of Aytu BioScience, Inc. (NASDAQ: AYTU) over potential breaches of fiduciary duties by certain directors at Aytu BioScience, Inc.

Investors who purchased shares of Aytu BioScience, Inc. (NASDAQ: AYTU) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Aytu BioScience, Inc. (NASDAQ: AYTU officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Englewood, CO based Aytu BioPharma, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. Aytu BioScience, Inc. reported that its Total Revenue rose from $27.63 million for the 12 months period that ended on June 30, 2020 to $65.63 million for the 12 months period that ended on June 30, 2021, and that its Net Loss over those respective time periods increased from $13.62 million to $58.28 million..

Shares of Aytu BioScience, Inc. (NASDAQ: AYTU) declined from $29.90 per share in March 2020 to as low as $2.19 per share on November 16, 2021.

Those who purchased shares of Aytu BioScience, Inc. (NASDAQ: AYTU) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Aytu BioScience, Inc. (NASDAQ: AYTU) here

News-ID: 2464542 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Aytu

Investigation announced for Investors in Aytu BioScience, Inc. (NASDAQ: AYTU)
An investigation on behalf of investors of Aytu BioScience, Inc. (NASDAQ: AYTU) shares over potential securities laws violations by Aytu BioScience, Inc. (NASDAQ: AYTU and certain of its directors and officers in connection with certain financial statements was announced. Investors who purchased shares of Aytu BioScience, Inc. (NASDAQ: AYTU), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm
NASDAQ: AYTU Investor Notice: Investigation over potential Securities Laws Viola …
Aytu BioScience, Inc is under investigation concerning potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Aytu BioScience, Inc. (NASDAQ: AYTU), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Aytu BioScience, Inc. (NASDAQ: AYTU) concerning whether a series of
Investigation announced for Long-Term Investors in NASDAQ: AYTU shares over pote …
An investigation was announced for current long-term investors in NASDAQ: AYTU shares over potential securities laws violations by Aytu BioScience, Inc. in connection with certain financial statements. Investors who purchased shares of Aytu BioScience, Inc. (NASDAQ: AYTU) prior to April 2020 and continue to hold any of those NASDAQ: AYTU shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a
Male Infertility Market May Set Huge Growth by 2026 | Halotech, Cadila Healthcar …
A Latest intelligence report published by AMA Research with title “Male Infertility Market Outlook to 2026.A detailed study accumulated to offer Latest insights about acute features of the Global Male Infertility market. This report provides a detailed overview of key factors in the Male Infertility Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. A thorough analysis of these factors including economic slowdown,
Aytu BioScience, Inc. (NASDAQ: AYTU) Investor Investigation over possible Securi …
An investigation was announced concerning potential securities laws violations by Aytu BioScience, Inc. in connection with certain financial statements. Investors who purchased shares of Aytu BioScience, Inc. (NASDAQ: AYTU), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Aytu BioScience, Inc. (NASDAQ: AYTU regarding its business, its prospects and its
Investigation for Investors in NASDAQ: AYTU shares over possible Wrongdoing at A …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Aytu BioScience, Inc. Investors who purchased shares of Aytu BioScience, Inc. (NASDAQ: AYTU) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Aytu BioScience directors breached their fiduciary duties and caused damage to the company and its shareholders. Englewood, CO